Annual ROA
-114.39%
-34.89%-43.89%
31 December 2023
Summary:
Monopar Therapeutics annual return on assets is currently -114.39%, with the most recent change of -34.89% (-43.89%) on 31 December 2023. During the last 3 years, it has fallen by -77.02% (-206.10%). MNPR annual ROA is now -261.54% below its all-time high of -31.64%, reached on 31 December 2019.MNPR ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-87.77%
+1.20%+1.35%
30 September 2024
Summary:
Monopar Therapeutics quarterly return on assets is currently -87.77%, with the most recent change of +1.20% (+1.35%) on 30 September 2024. Over the past year, it has dropped by -1.53% (-1.77%). MNPR quarterly ROA is now -154.70% below its all-time high of -34.46%, reached on 30 September 2018.MNPR Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.9% | -1.8% |
| 3 y3 years | -206.1% | -130.3% |
| 5 y5 years | -159.3% | -36.8% |
MNPR ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -206.1% | at low | -130.3% | +1.4% |
| 5 y | 5 years | -261.5% | at low | -142.3% | +1.4% |
| alltime | all time | -261.5% | +31.4% | -154.7% | +53.4% |
Monopar Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -87.77%(-1.3%) |
| June 2024 | - | -88.97%(+2.9%) |
| Mar 2024 | - | -86.49%(-1.9%) |
| Dec 2023 | -114.39%(+43.9%) | -88.19%(+2.3%) |
| Sept 2023 | - | -86.24%(+8.2%) |
| June 2023 | - | -79.69%(+6.8%) |
| Mar 2023 | - | -74.63%(+10.8%) |
| Dec 2022 | -79.50%(+79.2%) | -67.33%(+14.0%) |
| Sept 2022 | - | -59.05%(+10.9%) |
| June 2022 | - | -53.23%(+17.7%) |
| Mar 2022 | - | -45.23%(+16.0%) |
| Dec 2021 | -44.36% | -38.98%(+2.3%) |
| Sept 2021 | - | -38.11%(+5.2%) |
| June 2021 | - | -36.22%(-5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -38.50%(-7.4%) |
| Dec 2020 | -37.37%(+18.1%) | -41.57%(+10.3%) |
| Sept 2020 | - | -37.68%(-7.3%) |
| June 2020 | - | -40.63%(-4.9%) |
| Mar 2020 | - | -42.71%(-23.1%) |
| Dec 2019 | -31.64%(-28.3%) | -55.57%(-13.4%) |
| Sept 2019 | - | -64.14%(+14.2%) |
| June 2019 | - | -56.16%(+13.0%) |
| Mar 2019 | - | -49.69%(+26.2%) |
| Dec 2018 | -44.11%(-73.5%) | -39.36%(+14.2%) |
| Sept 2018 | - | -34.46%(-81.7%) |
| June 2018 | - | -188.41%(+5.4%) |
| Mar 2018 | - | -178.81%(+7.3%) |
| Dec 2017 | -166.69%(+307.2%) | -166.69% |
| Dec 2016 | -40.94% | - |
FAQ
- What is Monopar Therapeutics annual return on assets?
- What is the all time high annual ROA for Monopar Therapeutics?
- What is Monopar Therapeutics annual ROA year-on-year change?
- What is Monopar Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly ROA year-on-year change?
What is Monopar Therapeutics annual return on assets?
The current annual ROA of MNPR is -114.39%
What is the all time high annual ROA for Monopar Therapeutics?
Monopar Therapeutics all-time high annual return on assets is -31.64%
What is Monopar Therapeutics annual ROA year-on-year change?
Over the past year, MNPR annual return on assets has changed by -34.89% (-43.89%)
What is Monopar Therapeutics quarterly return on assets?
The current quarterly ROA of MNPR is -87.77%
What is the all time high quarterly ROA for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly return on assets is -34.46%
What is Monopar Therapeutics quarterly ROA year-on-year change?
Over the past year, MNPR quarterly return on assets has changed by -1.53% (-1.77%)